as on September 18, 2025 at 1:29 am IST
Day's Low
Day's High
0.16%
Downside
4.53%
Upside
52 Week's Low
52 Week's High
52.39%
Downside
13.99%
Upside
Check Ocular Therapeutix Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.2B
EPS (TTM)
-1.4925
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-9.65
Industry PE ratio
-3.9415151515151514
P/B Ratio
0PEG Ratio
0EBITDA
-237.3M
Revenue (TTM)
56.7M
Profit Margin
0.00%
Return On Equity TTM
10924000.00%
Track how Ocular Therapeutix Inc P/E has moved over time to understand its valuation trends.
Ocular Therapeutix Inc in the last 5 years
Lowest (0.00x)
September 18, 2025
Today (-9.65x)
September 18, 2025
Industry (-3.94x)
September 18, 2025
Highest (0.00x)
September 18, 2025
Today’s Price to Earnings Ratio: -9.65x
Compare market cap, revenue, PE, and other key metrics of Ocular Therapeutix Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $2.2B | 34.58% | -9.65 | 0.00% | |
BUY | $60.5B | 252.04% | -505.15 | -12.96% | |
NA | $39.0B | NA | NA | -3.89% | |
BUY | $100.3B | 44.17% | 27.85 | 31.86% | |
BUY | $59.6B | 1.78% | 14.1 | 31.37% |
The Ocular Therapeutix Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Ocular Therapeutix Inc investment value today
Current value as on today
₹1,38,852
Returns
₹38,852
(+38.85%)
Returns from Ocular Therapeutix Inc Stock
₹34,254 (+34.25%)
Dollar Returns*
₹4,598 (+4.6%)
Based on 14 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 14 analysts, 85.71% of analysts recommend a 'BUY' rating for Ocular Therapeutix Inc. Average target price of $17.75
Get share price movements and forecasts by analysts on Ocular Therapeutix Inc.
What analysts predicted
31.55%UPSIDE
Target Price
$17.75
Current Price
$12.15
Analyzed by
14 Analysts
Target
$17.75
Ocular Therapeutix Inc target price $17.75, a slight upside of 31.55% compared to current price of $12.15. According to 14 analysts rating.
Search interest for Ocular Therapeutix Inc Stock has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 3 months, OCUL stock has moved up by 46.0%
Revenue Rich
Revenue is up for the last 2 quarters, 10.63M → 13.45M (in $), with an average increase of 21.0% per quarter
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 34.0%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 4.3%
Profit Down
Netprofit is down for the last 4 quarters, -36.49M → -67.81M (in $), with an average decrease of 23.6% per quarter
Organisation | Ocular Therapeutix Inc |
Headquarters | 15 Crosby Drive, Bedford, MA, United States, 01730 |
Industry | Health Technology |
CEO | Dr. Pravin U. Dugel M.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Peter K. Kaiser M.D. | Chief Development Officer |
Mr. Donald Notman Jr. | CFO, COO & Principal Accounting Officer |
Mr. William H. Ransone II | Vice President of Global Sales & Marketing |
Mr. Steve Meyers | Chief Commercial Officer |
Dr. Jeffrey S. Heier M.D. | Chief Scientific Officer |
Dr. Peter K. Jarrett Ph.D. | Chief Technical Officer |
Mr. William S. Slattery Jr. | Vice President of Investor Relations |
Mr. Todd D.C. Anderman J.D. | Chief Legal Officer & Corporate Secretary |
Mr. Barry Rubenstein M.S. | Chief Human Resources Officer |
Dr. Pravin U. Dugel M.D. | Executive Chairman, President & CEO |
Ocular Therapeutix Inc share price today is $12.15 as on at the close of the market. Ocular Therapeutix Inc share today touched a day high of $12.7 and a low of $12.13.
Ocular Therapeutix Inc share touched a 52 week high of $13.85 on and a 52 week low of $5.79 on . Ocular Therapeutix Inc stock price today i.e. is closed at $12.15,which is 12.27% down from its 52 week high and 110.03% up from its 52 week low.
Ocular Therapeutix Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Ocular Therapeutix Inc (OCUL) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Ocular Therapeutix Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Ocular Therapeutix Inc share’s latest price of $12.15 as on September 18, 2025 at 1:29 am IST, you will get 0.8230 shares of Ocular Therapeutix Inc. Learn more about
fractional shares .
Ocular Therapeutix Inc stock has given 34.58% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?